Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wave Life Sciences to Present at Upcoming Investor Conferences
Plexus Issues Fiscal 2025 Sustainability Report and Announces Transition to Absolute Emission Reduction Targets
Brera Holdings PLC (NASDAQ: SLMT) (d/b/a Solmate Infrastructure) Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearing Cancelled
Hilton Launches Undergraduate by Hilton, Accelerating Lifestyle Portfolio Growth
Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
OSI Systems Receives $19 Million Order to Support Deployment of Non-Intrusive Inspection Solutions
Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis
Servier to Acquire Edgewise Therapeutics Muscular Dystrophy Business USA - English USA - English USA - Français
JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER